Mineralys Therapeutics, Inc. (NASDAQ: MLYS) will announce its financial results for the second quarter of 2025 on August 12, 2025, after the U.S. financial markets close. The company, based in Radnor, Pennsylvania, has also scheduled a conference call to discuss the results at 4:30 p.m. ET that same day.
Investors interested in participating in the call can dial 1-877-704-4453 for domestic calls within the United States or 1-201-389-0920 for international participants. The conference call will reference Conference ID 13754684 to facilitate access.
A live webcast of the event will be available on the “News & Events” section of the Investor Relations page on the company’s website, providing an accessible platform for stakeholders to engage with the company’s latest financial updates.
As Mineralys Therapeutics prepares to share its Q2 results, investors and analysts will be closely monitoring key performance indicators and any insights into the company’s strategic direction. This release follows the company’s ongoing efforts to advance its therapeutic innovations and expand its market presence.
For continuous updates on financial news and developments in Chester County and its surroundings, follow local news outlets and platforms like MyChesCo.
